Home > Insider Trading > Filing (0001225208-14-012015)

Filing Details

Accession Number:: 0001225208-14-012015
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-05 15:24:40
Reporting Period:: 2014-05-01

Filing Date:: 2014-05-05
Accepted Time:: 2014-05-05 14:24:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1453593	Bacterin International Holdings Inc.	BONE	Biological Products, (No Disgnostic Substances) (2836)	205313323

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1508469	S Guy Cook	246 Painted Hills Road Bozeman MT 59715		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-05-01	50,000	$0.71	3,240,049	No	4	S	Direct
Common Stock	Disposition	2014-05-02	230,000	$0.73	3,010,049	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,800,000	Indirect	By Michelle Allison Cook Trust
Common Stock	1,800,000	Indirect	By Steven Thomas Cook Trust
Common Stock	1,700,000	Indirect	By Timothy Shane Cook Trust

Footnotes

The reporting person recognizes that the transactions reported on this Form 4 are matchable under Section 16(b) of the Securities Exchange Act of 1934 in connection with the reporting person's purchase of 162,320 shares of common stock at a price of $.6426 per share on January 15, 2014. The reporting person has already paid to the issuer the profit realized in connection with the sale of 162,320 shares prior to the date of this transaction and this transaction does not result in any additional profit realized as calculated pursuant to the requirements of Section 16(b).
The price shown is a weighted average sale price for shares sold in multiple transactions; the sale prices ranged from $0.70 to $0.72 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The reporting person recognizes that the transactions reported on this Form 4 are matchable under Section 16(b) of the Securities Exchange Act of 1934 in connection with the reporting person's purchase of 162,320 shares of common stock at a price of $0.6426 per share on January 15, 2014. The reporting person has already paid to the issuer the profit realized with respect to the sale of 162,320 prior to the date of this transaction and will pay to the issuer the additional profit realized in connection with this transaction as calculated pursuant to the requirements of Section 16(b).
The price shown is a weighted average sale price for shares sold in multiple transactions; the sale prices ranged from $0.70 to $0.75 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.